Ann: Quarterly Activities Report, page-2

Happy to take an educated punt with this stock based on the recent increase in share price from $0.006 to $0.015 which was accompanied by high volume and is timed just prior to assay results which are due in early November. Something tells me the results should be positive based on the activity of the market during the last couple of weeks.

Time will tell, the upside is potentially massive considering the current tiny market cap but don't see it dropping too much further below current levels even if the news is disappointing from the upcoming results.